MedTrace Logo

Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)

NCT02094482 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-09-13

No results posted yet for this study

Summary

Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)

Conditions

  • Reduction of Initial AHI
  • Reduction of Initial Snoaring Index

Interventions

DEVICE

The IMD is a resilient palatal implant which is introduced through a stab incision into the palate.

The IMD is a resilient palatal implant which is introduced through a stab incision into the palate. Two implants are placed underneath the rostral part of the palatal bone and continue into the upper part of the soft palate

Sponsors & Collaborators

  • Medartis AG

    lead INDUSTRY

Principal Investigators

  • Kurt Tschopp, MD · Kantonsspital Liestal

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2020-07-31
Completion
2020-10-31

Countries

  • Switzerland

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094482 on ClinicalTrials.gov